Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO WCGIC 2020 | Impact of COVID-19 on HCC management

Bruno Sangro, MD, PhD, of Clinica Universidad de Navarra, Navarra, Spain, describes the impact of COVID-19 on hepatocellular carcinoma (HCC) treatment. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).